Trademark: 74660335
Status Date
Friday, April 17, 2020
Registration Number
2058625
Registration Date
Tuesday, May 6, 1997
Filing Date
Monday, April 10, 1995
Published for Opposition
Tuesday, February 11, 1997
Cancellation Date
Friday, April 17, 2020
5 house mark for pharmaceutical preparations for the treatment of cancer, [autoimmune diseases, ]blood disorders, platelet depletion [and for the repair and regeneration of cartilage, bones, tissues and internal organs]
Apr 17, 2020
Cancelled Sec. 8 (10-Yr)/Expired Section 9
May 6, 2016
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jul 13, 2010
Teas Change Of Correspondence Received
Nov 18, 2008
Notice Of Design Search Code Mailed
Apr 24, 2007
Registered And Renewed (First Renewal - 10 Yrs)
Apr 24, 2007
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Apr 19, 2007
Assigned To Paralegal
Mar 22, 2007
Registered - Combined Section 8 (10-Yr) & Sec. 9 Filed
Mar 22, 2007
Teas Section 8 & 9 Received
Dec 14, 2006
Case File In Ticrs
Aug 4, 2002
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 18, 2002
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Jun 18, 2002
Teas Section 8 & 15 Received
May 6, 1997
Registered-Principal Register
Feb 11, 1997
Published For Opposition
Jan 10, 1997
Notice Of Publication
Dec 5, 1996
Approved For Pub - Principal Register
Jun 6, 1996
Final Refusal Mailed
Mar 25, 1996
Correspondence Received In Law Office
Oct 12, 1995
Non-Final Action Mailed
Sep 14, 1995
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
